Cellular proliferation at an enhanced rate at tumor sites gives rise to hypoxia, low concentration of oxygen that stabilizes HIF-1α, which activates NFκB to secrete an angiogenic protein, VEGF and also induces expression of IL-12 and TNF-α. Here, HIF1A is linked to neoplasm.